Institutional Exposure To The Pennant Group Inc. (PNTG)

After grabbing 4.11 million shares, the institutional investor is now in possession of 4.11 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 13.86% having worth around $45.15 million. Moreover, BlackRock Fund Advisors increased its share by 46518.0 to have a control over 4.05 million shares. And The Vanguard Group, Inc. raised its holdings to 43334.0 shares by acquiring 2.43 million shares or 8.19% of the stake.

The Pennant Group Inc. (PNTG) concluded trading on 01/19/23 at a closing price of $11.82, with 0.15 million shares of worth about $1.72 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -6.64% during that period and on Thursday the price saw a gain of about 2.69%. Currently the company’s common shares owned by public are about 29.34M shares, out of which, 27.10M shares are available for trading.

A deeper look into what the analysts at Wall Street are thinking about the price target of this stock provides us with the following: 5 analysts are covering the PNTG stock and their offered price forecasts bring an average price target of $15.40. Over the next 12 months, analysts forecasted that the stock’s price could jump as high as $18.00 and could fall to a lowest price of $12.00. The stock’s current price level is 23.25% above of average price target set by the analysts, while a rise to estimated low would result in gain of 1.5% for the stock. However, touching the estimated high of $18.00 would mean a gain of 34.33% for the stock.

According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 36 times over the past 12 months. They bought 201,250 shares in 30 of the transactions. In 6 selling transactions, insiders dumped 254,585 shares.

iShares Core S&P Small Cap ETF, Wasatch Small Cap Growth Fund, and T Rowe Price Small Cap Value Fund are the top 3 mutual funds which are holding stakes in The Pennant Group Inc. iShares Core S&P Small Cap ETF is currently holding 2.1 million shares of worth totaling $23.09 million. The company recently came selling 11411.0 shares which brought its stake up to 7.09% of the company’s outstanding shares. Wasatch Small Cap Growth Fund sold 61876.0 shares, after which its hold over company’s outstanding shares shrunk to 6.60%, leaving 1.96 million shares with the mutual fund that have a worth of about $21.5 million. T Rowe Price Small Cap Value Fund, after buying 1.51 million shares, have now control over 5.10% of the stake in the company. It holds 0.16 million shares of worth $16.61 million.

The Pennant Group Inc. (NASDAQ: PNTG) started trading at $11.37, below -$0.14 from concluding price of the previous day. However, the stock later moved at a day high price of 11.90, or with a gain of 2.69%. Stock saw a price change of 13.33% in past 5 days and over the past one month there was a price change of 1.46%. Year-to-date (YTD), PNTG shares are showing a performance of 7.65% which decreased to -32.26% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $8.68 but also hit the highest price of $20.28 during that period. The average intraday trading volume for The Pennant Group Inc. shares is 202.13K. The stock is currently trading 9.94% above its 20-day simple moving average (SMA20), while that difference is up 9.30% for SMA50 and it goes to -13.99% lower than SMA200.

T. Rowe Price Investment Manageme acquired 4.11 million shares of The Pennant Group Inc. having value of about $45.15 million. The Pennant Group Inc. (NASDAQ: PNTG) currently have 29.34M outstanding shares and institutions hold larger chunk of about 88.70% of that. Holding of mutual funds in the company is about 58.45% while other institutional holders and individual stake holders have control over 8.45% and 21.29% of the stake respectively.

The stock has a current market capitalization of $344.20M. PE ratio of stock for trailing 12 months is 472.80, while it has posted earnings per share of $0.03 in the same period. Its PEG reads 11.53 and has Quick Ratio of 0.90 while making debt-to-equity ratio of 0.48. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for PNTG, volatility over the week remained 6.99% while standing at 6.54% over the month.

Analysts are in expectations that The Pennant Group Inc. (PNTG) stock would likely to be making an EPS of $0.18 in the current quarter, while forecast for next quarter EPS is $0.21 and it is $0.81 for next year. For the current quarter EPS, analysts have given the company a lowest target $0.17 which is $0.19 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of $0.11 in the same quarter a year ago. Stock’s fiscal year EPS is expected to drop by -83.10% while it is estimated to increase by 27.62% in next year. EPS is likely to grow at an annualized rate of 41.00% for next 5-years, compared to annual growth of -21.50% made by the stock over the past 5-years.

Analysts at 5 brokerage firms have issued recommendations for the The Pennant Group Inc. (PNTG)’s stock and average of those rates the stock at a “Moderate Buy” and assign it a score of 2.40. Out of those 5 Wall Street analysts, 2 recommended a “Buy” rating, while 3 were in favor recommending the stock as a “Hold” and 0 analyst recommended the stock as “Sell”.

Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Oppenheimer on August 25, 2022 offering an Outperform rating for the stock and assigned a target price of $22 to it. Coverage by Stephens stated The Pennant Group Inc. (PNTG) stock as an Equal-weight in their note to investors on June 21, 2022, suggesting a price target of $17 for the stock. On March 01, 2022, Stifel Downgrade their recommendations, while on September 21, 2021, Stifel Initiated their ratings for the stock with a price target of $37. Stock get an Outperform rating from RBC Capital Mkts on June 10, 2021.